Compounds > tert-butanesulfinamide
Page last updated: 2024-12-10

tert-butanesulfinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tert-butanesulfinamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3382465
SCHEMBL ID5598
MeSH IDM0499478

Synonyms (94)

Synonym
tert-butanesulfinamide
2-methyl-2-propanesulfinamide, 97%, racemic
2-methylpropane-2-sulfinamide
(s)-(-)-tert-butanesulfinamide
2-methyl-2-propanesulfinamide
A6048
2-methyl-propane-2-sulfinic acid amide
A3195
AKOS007930891
(s)-(-)-tert-butyl sulfinamide
146374-27-8
(+/-)-tert-butyl sulfinamide
B2926
tert-butylsulfinamide
(r)-2-methyl-2-propanesulfinamide
2-propanesulfinamide, 2-methyl-, [s(r)]-
FT-0644465
FT-0643836
tert-butylsulphinamide
tert-butyl sulfinamide
t-butylsulfinamide, racemic
AM20080353
2-propanesulfinamide, 2-methyl
PB24744
t-butylsulfinamide
SCHEMBL5598
(r)-(+)-tert-butanesulfinamide
SY008236
SY012206
mfcd01863616
SY006657
J-502314
J-502103
(s)-tert-butylsulfinamide
1,1-dimethylethylsulfinamide
2-methylpropane-2-sulphinamide
2-methyl propane-2-sulfinamide
s-tert-butyl sulfinamide
(+/-)-2-methyl-2-propanesulfinamide
2-methly-2-propanesulfinamide
(-)-tert-butylsulfinamide
2-methyl-propan-2-sulphinic acid amid
tert.butylsulfinamide
racemic 2-methyl-2-propanesulfinamide
s-(-)-t-butyl-sulfinamide
tert-butyl sulphinamide
2-methyl-2-propane sulfinamide
racemic-t-butylsulfinamide
racemic 2-methylpropane-2-sulfinamide
2-methylpropane -2-sulfinamide
tert butyl sulfinamide
2-methyl-propane-2-sulfinamide
2-methyl-2-propane-sulfinamide
racemic 2-methyl-2-propane-sulfinamide
(+/-)-2-methylpropane-2-sulfinamide
CESUXLKAADQNTB-UHFFFAOYSA-N
t-butylsulphinamide
STR08950
unii-i85yc2za8o
unii-7fec1t720f
unii-42f4k704g0
tbsa cpd
r-(+)tertbutylsulfinamide
(s)-(?)-2-methyl-2-propanesulfinamide
2-propanesulfinamide, 2-methyl-, (r)-
tert-butylsulfinamide, (s)-(-)-
ellman's sulfinamide
tert-butanesulfinamide, (s)-(-)-
2-propanesulfinamide, 2-methyl-, (s(s))-
7FEC1T720F ,
42F4K704G0 ,
tert-butylsulfinamide, (+/-)-
tert-butylsulfinamide, (r)-(+)-
2-methylpropan-2-sulfinamide
2-propanesulfinamide, 2-methyl-
2-propanesulfinamide, 2-methyl-, (s(r))-
I85YC2ZA8O ,
DTXSID20391967
2-methyl-2-propanesulfinamide,racemic
J-510083
F0001-0700
CS-W008628
DTXSID90463241
AC-6446
t-butanesulfinamide
s-tert-butylsulfinamide; (s)-(-)-t-butylsulfinamide
BCP14651
BCP26390
s)-(-)-2-methyl-2-propanesulfinamide
Q7705231
(+/-)-tert-butylsulfinamide
EN300-103954
SB21679
HY-34480
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's10 (90.91)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.99 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index24.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
glyoxylic acid
glyoxylic acid: RN given refers to parent cpd. glyoxylic acid : A 2-oxo monocarboxylic acid that is acetic acid bearing an oxo group at the alpha carbon atom.		2.07102-oxo monocarboxylic acid;
aldehydic acid		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
phenanthrene
phenanthrene : A polycyclic aromatic hydrocarbon composed of three fused benzene rings which takes its name from the two terms 'phenyl' and 'anthracene.'		2.110ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes		environmental contaminant;
mouse metabolite
pyrazole
1H-pyrazole : The 1H-tautomer of pyrazole.		2.0710pyrazole
cyanides
Cyanides: Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical.. cyanides : Salts and C-organyl derivatives of hydrogen cyanide, HC#N.. isocyanide : The isomer HN(+)#C(-) of hydrocyanic acid, HC#N, and its hydrocarbyl derivatives RNC (RN(+)#C(-)).. cyanide : A pseudohalide anion that is the conjugate base of hydrogen cyanide.		2.110pseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor
isatin
tribulin: endogenous MONOAMINE OXIDASE inhibitory activity extractable into ethyl acetate found in brain and many mammalian tissues and fluids; ISATIN is a major component; produced in excess following alcohol withdrawal;		2.110indoledioneEC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
allyl bromide
[no description available]		7.0510
allylamine
Allylamine: Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation.		2.0510alkylamine
alkenes
[no description available]		7.0710
1,7-phenanthroline
[no description available]		2.110phenanthroline
trimethylsilyl cyanide
[no description available]		2.110
tylophorine
tylophorine: phenanthroindolizidine alkaloid		7.110organic heteropentacyclic compound;
organonitrogen heterocyclic compound
cryptopleurine
cryptopleurine: plant bark alkaloid shown to inhibit protein synthesis; RN given refers to (R)-isomer; structure. cryptopleurine : An organic heteropentacyclic compound that is (14aR)-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups.		7.110alkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound		antineoplastic agent;
antiviral agent;
protein synthesis inhibitor
antofine
antofine: structure in first source. (-)-antofine : An organic heteropentacyclic compound that is (13aR)-9,11,12,13,13a,14-hexahydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups. It is an alkaloid produced by relatives of the milkweed family and exhibits antiviral, anti-inflammatory, antiadipogenic and antitumorigenic activities.		7.110alkaloid antibiotic;
alkaloid;
aromatic ether;
organic heteropentacyclic compound		angiogenesis inhibitor;
anti-inflammatory agent;
antimicrobial agent;
antineoplastic agent;
antiviral agent;
phytotoxin;
plant metabolite
phenanthrenes
Phenanthrenes: POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.. phenanthrenes : Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.		2.110
ConditionIndicatedRelationship StrengthStudiesTrials